abrdn Life Sciences Investors (HQL) Insider Trading & Ownership $13.14 +0.07 (+0.50%) As of 11:25 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsDividendHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock abrdn Life Sciences Investors (NYSE:HQL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage10.06%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$25.52KNumber OfInsiders Selling(Last 12 Months)18Amount OfInsider Selling(Last 12 Months)$4.08M Get HQL Insider Trade Alerts Want to know when executives and insiders are buying or selling abrdn Life Sciences Investors stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address HQL Insider Buying and Selling by Quarter abrdn Life Sciences Investors Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/20/2025Saba Capital Management, L.P.Major ShareholderSell11,419$12.71$145,135.49 5/15/2025Saba Capital Management, L.P.Major ShareholderSell23,729$12.08$286,646.32 5/14/2025Saba Capital Management, L.P.Major ShareholderSell600$12.04$7,224.00 5/13/2025Saba Capital Management, L.P.Major ShareholderSell730$12.28$8,964.40 5/7/2025Saba Capital Management, L.P.Major ShareholderSell1,366$12.19$16,651.54 4/17/2025Saba Capital Management, L.P.Major ShareholderSell9,144$11.78$107,716.32 4/14/2025Saba Capital Management, L.P.Major ShareholderSell15,400$11.67$179,718.00 4/10/2025Saba Capital Management, L.P.Major ShareholderSell30,156$11.14$335,937.84 4/4/2025Saba Capital Management, L.P.Major ShareholderSell6,889$11.57$79,705.73 4/2/2025Saba Capital Management, L.P.Major ShareholderSell29,102$12.28$357,372.56 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 3/31/2025Saba Capital Management, L.P.Major ShareholderSell48,623$12.58$611,677.34 3/27/2025Saba Capital Management, L.P.Major ShareholderSell32,922$13.01$428,315.22 2/26/2025Saba Capital Management, L.P.Major ShareholderSell200$13.62$2,724.00 2/12/2025Saba Capital Management, L.P.Major ShareholderSell36,536$13.75$502,370.00 2/10/2025Saba Capital Management, L.P.Major ShareholderSell42,987$13.95$599,668.65 2/3/2025Saba Capital Management, L.P.Major ShareholderSell1,846$14.03$25,899.38 1/31/2025Saba Capital Management, L.P.Major ShareholderSell15,143$14.27$216,090.61 1/29/2025Saba Capital Management, L.P.Major ShareholderSell11,674$14.12$164,836.88 8/23/2024Bill MaherDirectorBuy650$15.37$9,990.50 7/16/2024Rose DimartinoDirectorBuy1,000$15.53$15,530.00 (Data available from 1/1/2013 forward) HQL Insider Trading Activity - Frequently Asked Questions Who is on abrdn Life Sciences Investors' Insider Roster? The list of insiders at abrdn Life Sciences Investors includes Bill Maher, Daniel R Omstead, Kathleen Goetz, Rose Dimartino, Saba Capital Management, L.P., and Todd Reit. Learn more on insiders at HQL. What percentage of abrdn Life Sciences Investors stock is owned by insiders? 10.06% of abrdn Life Sciences Investors stock is owned by insiders. Learn more on HQL's insider holdings. Which abrdn Life Sciences Investors insiders have been buying company stock? The following insiders have purchased HQL shares in the last 24 months: Bill Maher ($9,990.50), Daniel R Omstead ($277,249.44), Kathleen Goetz ($5,328.00), Rose Dimartino ($15,530.00), Saba Capital Management, L.P. ($6,156,313.77), and Todd Reit ($13,800.00). How much insider buying is happening at abrdn Life Sciences Investors? Insiders have purchased a total of 486,559 HQL shares in the last 24 months for a total of $6,478,211.71 bought. Which abrdn Life Sciences Investors insiders have been selling company stock? The following insider sold HQL shares in the last 24 months: Saba Capital Management, L.P. ($4,076,654.28). How much insider selling is happening at abrdn Life Sciences Investors? Insiders have sold a total of 318,466 abrdn Life Sciences Investors shares in the last 24 months for a total of $4,076,654.28 sold. abrdn Life Sciences Investors Key ExecutivesDr. Daniel R. Omstead M.S (Age 71)Ph.D., Principal Executive Officer, President and Trustee Mr. Peter BrannerChief Investment Officer More Insider Trading Tools from MarketBeat Related Companies CET Insider Trading GSBD Insider Trading MFIC Insider Trading NMFC Insider Trading PFLT Insider Trading BCSF Insider Trading BBDC Insider Trading AWF Insider Trading HQH Insider Trading BTO Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Small Caps Drawing Insider and Institutional SupportDo They Know Something? Insiders & Congress Buy UnitedHealthMicron Insiders Sell But Investors Should Buy, Buy, BuySizzling Insider Buys for Your High-Yield WatchlistInsider Selling at NVIDIA Could Turn Into an Opportunity This page (NYSE:HQL) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersRefund From 1933: Trump’s Reset May Create Instant WealthTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredThe Next Commodity Crisis Just Got a Name: SilverElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding abrdn Life Sciences Investors Please log in to your account or sign up in order to add this asset to your watchlist. Share abrdn Life Sciences Investors With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.